COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica:Disclosure of Share Capital and Voting Rights Outstanding as of October 2, 2018

03/10/2018 - 18:01

Disclosure of Share Capital and Voting Rights Outstanding as of October 2, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 2 octobre 2018

03/10/2018 - 18:01

Nombre total de droits de vote et d'actions composant le capital social au 2 octobre 2018 (Conformément à l'article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton [...]

VALNEVA : Declaration d'actions et de droits de vote - septembre 2018

03/10/2018 - 18:01

VALNEVA Déclaration d'actions et de droits de vote - SEPTEMBRE 2018 Dénomination sociale : VALNEVA Adresse du siège social : 6 rue Alain Bombard, 44800 Saint-Herblain Marché réglementé Euronext Paris de Nyse Euronext - [...]

Nymox Reports Safety Benefits of Fexapotide Treatments for Prostate Cancer and Benign Prostatic Hyperplasia

03/10/2018 - 17:46

Excellent Safety Record Reinforced With Short-Term and Long-Term Safety Results of Repeated Injections of Fexapotide in 344 Patients Given Repeated Injections and Followed For 7 Years in 2 U.S. Trials HASBROUCK HEIGHTS [...]

Pharmacokinetic Profile of Trogarzo™ Presented at IDWeek

03/10/2018 - 17:26

MONTREAL, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that pharmacokinetic data from the pivotal phase III clinical trial for Trogarzo™ (ibalizumab-uiyk [...]

Le profil pharmacocinétique de Trogarzo(MC) présenté à IDWeek

03/10/2018 - 17:26

MONTRÉAL, 03 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que des données pharmacocinétiques provenant de l’étude pivot de phase III de Trogarzo MC ( [...]

Cannabis education starts before legal age of consumption

03/10/2018 - 17:08

HALIFAX, Nova Scotia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- To prepare for Canada’s Oct. 17 cannabis legalization, TeenMentalHealth.Org is educating students, parents, teachers and school-based student care providers about [...]

Molina Healthcare Announces Third Quarter 2018 Earnings Release and Conference Call Dates

03/10/2018 - 17:00

LONG BEACH, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the third quarter ended September 30, 2018. Molina Healthcare will [...]

The Right to Be Treated: Overcoming Bias & Discrimination in Obesity Care

03/10/2018 - 16:27

WINNIPEG, Manitoba, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Who: Reporters and editors covering health, wellness, diet, exercise, healthcare delivery, human rights and politics. What: To mark impending legislation aimed at [...]

Xyngular Named One of Inc. 5000’s Fastest Growing Companies in America for 3rd Year in a Row

03/10/2018 - 16:03

LEHI, Utah, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Xyngular, a leading provider of simplified weight-loss systems headquartered in Lehi, Utah, has made Inc. 5000’s list of fastest growing companies in America for the third [...]

Aura Appoints New Director

03/10/2018 - 15:58

TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE: BUZZ ) wishes to announce the following changes to its board of directors (the “ Board ”). Effective immediately, Joel [...]

The Alliance for Regenerative Medicine Announces Election of 2019 ARM Officers, Executive Committee, and Board of Directors

03/10/2018 - 15:00

WASHINGTON, D.C., Oct. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative [...]

Medibio Releases Corporate Health Product, ilumen™

03/10/2018 - 15:00

SYDNEY, Australia and MINNEAPOLIS, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the release of ilumen™, its [...]

The Race to Speed Up the Effects of Cannabis -- CFN Media

03/10/2018 - 15:00

SEATTLE, Oct. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Phoenix Life Sciences International Announces New Board of Directors and Executive Team

03/10/2018 - 15:00

DENVER, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: MJMD) (“Phoenix Life”), an adaptive healthcare solutions company, today announced its new Board of Directors and executive team [...]

CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials

03/10/2018 - 15:00

CENTOGENE to conduct a targeted global identification and recruitment campaign to support Denali´s LRRK2 inhibitor program ROSTOCK, Germany and SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CENTOGENE [...]

Technology Innovators, Experienced Systems Integrators Join Cerner in Mission to Modernize Veterans' Electronic Health Records

03/10/2018 - 15:00

KANSAS CITY, Mo. , Oct. 03, 2018 (GLOBE NEWSWIRE) -- Today, Cerner announced it has established a team of industry leaders and innovators with extensive experience in large enterprise systems and commercial sectors to [...]

MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes

03/10/2018 - 15:00

Presentation 55 Total and severe hypoglycemia is reduced with use of inhaled Technosphere® Insulin (TI) relative to insulin aspart in type 1 diabetes Poster 1046; PS 097 Diabetes duration, BMI, and HbA1c have greater [...]

Cue Biopharma Appoints Hon. Randall R. Rader to Chair Company’s Intellectual Property Committee

03/10/2018 - 15:00

CAMBRIDGE, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]